version dated 13 November 2008.8.Bioavailability and Bioequivalence Studies for Orally Administered DrugProducts-General Considerations; Guidance for Industry; US Department of Healthand Human Services, Food and Drug Administration, Center for Drug
Evaluationand Research,Washington, D.C., March 2003.声明:本文由药事纵横编辑Herman翻译,转载务必获得药事纵横许可,并注明来源和作者(原作者和翻译作者),否则一律认定为侵权。作者微信号:Hermans807,欢迎探讨与交流。